APA (7th ed.) Citation

Zander, M., Taskiran, M., Toft-Nielsen, M., Madsbad, S., Holst, J. J., Zander, M., . . . Holst, J. J. (2001). Additive glucose-lowering effects of glucagon-like peptide-1 and metformin in type 2 diabetes. Diabetes Care, 24(4), 720. https://doi.org/10.2337/diacare.24.4.720

Chicago Style (17th ed.) Citation

Zander, Mette, et al. "Additive Glucose-lowering Effects of Glucagon-like Peptide-1 and Metformin in Type 2 Diabetes." Diabetes Care 24, no. 4 (2001): 720. https://doi.org/10.2337/diacare.24.4.720.

MLA (9th ed.) Citation

Zander, Mette, et al. "Additive Glucose-lowering Effects of Glucagon-like Peptide-1 and Metformin in Type 2 Diabetes." Diabetes Care, vol. 24, no. 4, 2001, p. 720, https://doi.org/10.2337/diacare.24.4.720.